CHI Mercy Hospital announced that its 2025 Casino Night Gala raised $90,000 dedicated to the establishment of the Debbie Gabel Infusion Center. This achievement marks a crucial step in bringing ...
The TCC and Intermountain Health partnership provides local cancer care in Fairbanks, reducing travel for Alaska Native ...
Matisse Pharmaceuticals B.V. was founded in 2014 in Geleen, the Netherlands. Matisse is dedicated to develop a product ...
MONTROSE, Colo. (KJCT) - Montrose Regional Health held a grand opening for the new Francie Smiles Infusion Center, expanding ...
Pertuzumab-dpzb is the first interchangeable biosimilar to pertuzumab, enhancing treatment accessibility for HER2-positive ...
Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...
GROVETOWN, Ga. (WRDW/WAGT) - Construction continues on the new Wellstar hospital in Columbia County, located just off the ...
GREENVILLE, S.C. (FOX Carolina) - A groundbreaking device is changing how doctors treat colorectal cancer by targeting tumors while sparing the rest of the body from chemotherapy side effects. Hope ...
The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...
Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to ...
MedPage Today on MSN
Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar
The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody commonly used in standard regimens for HER2-positive breast cancer. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback